Humanigen, Inc.
from OTCQB Podcast Hosted by OTC Markets Group
Humanigen, Inc. (OTCQB: HGEN) is a biopharmaceutical company pursuing cutting-edge science to develop our proprietary monoclonal antibodies for immunotherapy and oncology treatments. Joining our podcast today is Cameron Durrant, Chairman and CEO.
Embed this episode
No transcript yet.
Similar podcasts
Frequently asked questions
How long is this episode of OTCQB Podcast?
This episode is 8 minutes long.
When was this OTCQB Podcast episode published?
This episode was published on May 9, 2018.
Can I download this OTCQB Podcast episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.